Amgen Launches Environmental Sustainability Plan, Targets Carbon Neutrality by 2027
Biotechnology company Amgen announced today the launch of a new seven year environmental sustainability plan, with goals including reaching carbon neutrality, as well as reductions in water use of 40%, and waste disposals of 75%. The new targets come on top of the company’s achievements in these areas since 2007, which include a 33% reduction in carbon emissions, a 30% reduction in water use and a 28% reduction in waste.
In order to achieve its new sustainability goals, Amgen expects to invest more than $200 million, focusing on the use of innovative technologies to significantly reduce carbon emissions from company-owned operations, and on sourcing renewable energy. According to the company, the investments will not only help Amgen achieve its sustainability objectives, but will also help it become more flexible and productive, with the efficiencies generated resulting in reductions in operating costs.
The company stated that in areas where carbon emissions cannot be eliminated from its operations, it will invest in sustainability projects that sequester or avoid greenhouse gas emissions. In addition, Amgen will engage with its suppliers to assist and encourage carbon reductions throughout its value chain.
Robert A. Bradway, Chairman and Chief Executive Officer at Amgen, said:
“As a science-based company with a mission to serve patients, we understand the profound impact that climate change is having on human health around the world. Our new commitments expand on our previous achievements and drive Amgen’s continued leadership on environmental sustainability that will benefit our patients, staff, shareholders and communities.”